Braavos Investment Advisers

🏆 Oxford Ionics has set a new world record! In a paper released today, we announced that Oxford Ionics quantum chips are the highest performing in the world. Leveraging our state-of-the-art trapped ion technology, we’ve set records in both two-qubit gate and single-qubit gate performance. Coupled with the scalability of Oxford Ionics quantum chips, these results indicate that the era of commercially-valuable quantum computing is much closer than previously thought. 👉 Follow the link to learn more about this groundbreaking milestone: https://lnkd.in/dfkxWrBH For all the gory details, you can find the full scientific paper here: https://lnkd.in/dHaqUPQs National Quantum Computing Centre (NQCC) #OxfordIonics #quantumcomputing #quantumtechnology #innovation #qubits #quantumcomputer #iontrapping

Braavos congratulates Ali and the PQShield team on this milestone. We have watched the company evolve over the last 6 years, with the most talented technical team globally in post-quantum cryptography. We believe PQShield will be a category-defining company, and we're excited to be a part of this journey.

So proud to be part of this journey with PQShield and my dear friend Ali Kaafarani. It wasn't the best climate to raise funds, but the $37m outcome speaks for itself. The team at PQShield is the best I've ever seen, and we get to work with amazing customers every day. Here we come 🚀

I'm excited to share that today, OXCCU TECH LTD has announced its agreement with px Group to develop our First-of-a-Kind (FOAK) OX2 demonstration plant at Saltend Chemicals Park in the #Humber region. The project will directly convert carbon dioxide and green hydrogen into jet fuel range hydrocarbons suitable for #SAF, a novel approach to production as it simplifies what is normally a multi-step process to a single step. This partnership aligns directly with the Department for Transport (DfT), United Kingdom's #AdvancedFuelFund’s objective of developing the use carbon dioxide as a carbon source for SAF production due to feedstock concerns associated with other biofuel SAF pathways. Many thanks to the px Group team not least Patrick Pogue, John Copping, Michael Forgie, Geoff Holmes, Stephen Lowdon, Paul Keenan, Hayley Davidson, Jane Goult. You can read more about our partnership here: https://lnkd.in/eBQytqsW

#PortfolioNews - Congratulations to Aidan Crawley and the team at Amber Therapeutics for raising $100 million in its Series A financing - one of the largest Series A rounds for a European medical technology company 👏 . Amber's CEO Aidan was an Entrepreneur-in-Residence at OSE before spinning out the company and we're proud to have been part of Amber's journey from the beginning! Amber has the potential to improve the lives of millions of women globally affected by mixed urinary incontinence, a debilitating medical condition, and this round will go to further developing the company's breakthrough therapy and working towards US regulatory approval. We supported Amber's round alongside lead investor New Enterprise Associates (NEA) and a syndicate of investors including F-Prime Capital, Lightstone Ventures, Intuitive Ventures and 8VC. Full announcement here ⤵ https://rb.gy/zdy0rr

Thank you Origami Labs for sharing your experience of working with our camera! We are so excited to see how our customers are utilising the Living Optics camera for their projects. We're excited to track their progress, and we couldn’t be prouder of our team for all the hard work that made accessible #hyperspectral #vision a reality. The Living Optics camera is a VIS-NIR video-rate spectral imaging camera designed for computer vision developers and researchers; it enables them to explore the value of spectral information for their applications. Our users capture full frame spatial and spectral information at video frame rates and can analyse the data in real time thanks to our complete development kit solution. If you have an application that might benefit from the use of our snapshot HSI camera, get in touch. We are currently looking for partners to test large scale application feasibility in agricultural environments and beyond 💡 #computervision ; #imaging Origami Labs on LinkedIn: We’ve been busy… — Origami Labs https://lnkd.in/dBuDPM6d

#PortfolioNews - Today SpyBiotech announced a sponsored research agreement with University of Oxford for the development of a vaccine against Epstein-Barr virus (EBV). Mark Leuchtenberger, CEO of SpyBiotech, "This research collaboration is an important step forward on a commonly spread virus with no currently available vaccines or therapeutics for its prevention or spread." Full announcement details ⤵ https://lnkd.in/grpxjbhy

If you ever want me to talk at you for 40 minutes straight. NVIDIA AI's podcast has got you covered (in a few weeks). Thank you Noah Kravitz for putting up with me and thank you to Chiara Refäuter for tolerating me the last few months!

The Bill & Melinda Gates Foundation is collaborating with CHARM Therapeutics to enable the deployment of our advanced 3D deep learning technology DragonFold to address the health challenge of tuberculosis, a disease that impacts millions worldwide. DragonFold will be trained on AgriLife Research’s comprehensive dataset on Mycobacterium tuberculosis, and deployed to discover new compounds that could lead to innovative treatments and prevention strategies for this highly pervasive disease, as part of the Gates Foundation’s global mission to combat poverty, disease, and inequity. Stay tuned for updates on our journey towards new solutions in healthcare. #tuberculosis #collaboration #deeplearning #AI